Press releases
220502 – Emotra – PR – Emotra’s CFO appointed acting President
220427 – Emotra – PR – Communiqué Extraordinary shareholder meeting
220408 – Emotra – PR – Updated financial calendar 2022
220316 – Emotra – PR – Trading during the period until official listing
220311 – Emotra – PR – President has notified he will be stepping down
220307 – Emotra – PR – Comments on Spotlight’s decision to de-list
220221 – Emotra – PR – Plans for the period without official exchange trading
220218 – Emotra – PR – Listing review at Spotlight halted
220207-Emotra-PR-Publication-EUDOR_A
220206 – Emotra – PR – Resignation of two board members
220117 – Emotra – PR- Disclosure Notice and New Number of Shares
211214 – Emotra – PR – Result of subscription warrants series TO 2
211207 – Emotra – PR – Mangold Insight publishes analysis of Emotra AB
211126 – Emotra- PR – Emotra, exercise price for subscription warrants in TO2 series
211126 – Emotra- PR – Emotra finalizes its acquisition of NeuraMetrix
211125- Emotra – PR – Emotra insiders intend to exercise subscription warrants in TO2 2021 series
211125 – Emotra- PR – Dispute with Italian supplier finally resolved
211115 – Emotra- PM – Daniel Rudeklint appointed CFO
211027 – Emotra – PM – Publication of interim report postponed to November 29
210831 – PM – Emotra AB has reached conditional agreement to acquire NeuraMetrix
210707 – Emotra- PM – Emotra is granted patent protection in Canada
210709 – Emotra – PM – Emotra signs agreement with Kings College
20210617 – Emotra- PM – Freferential share issue for underwriters
20210615 – Emotra- PM – Rights issue outcome
210609 – Emotra – PM – Emotra signs agreement with NIMH
20210608 – Emotra- PM – CEO interview and analysis from Mangold Insight
210602 – Emotra – PM – Emotra participates at Småbolagsdagarna 2021
210422 – Emotra- PM – Board changes
210415 – Emotra – PM – Emotra signs Letter Of Intent with BLC
210215 – Emotra- PM – Publication in BMC Psychiatry
201229 – Emotra – PM – Emotra, overview for 2021
201221 – Emotra- PM – First relapse study accepted for publication in BMC Psychiatry
201120 – Emotra- PM – Notice of EGM
201026 – Emotra – PM – Result subscription warrants of TO 2020 series
201016 – Emotra – PM – CEO Daniel Poté intends to exercise subscription warrants
201009 – Emotra – PM – Emotra enters agreement to develop the german market
201008 – Emotra – PM – Chairman Claes Holmberg intends to convert subscription warrants
201007 – Emotra – PM – Emotra, postpones publication of 3q report
201007 – Emotra – PM – Emotra, exercise price for subscription warrants in to 2020
200929 – Emotra – PM – Emotra, update on research
2000908 – Emotra- PM – Presentation at Aktiespararna’s shareholder day
200603 – Emotra- PM – Communique from AGM
200528 – Emotra – PM – Claim form served concerning debt
200526 – Emotra – PM – Emotra is collaborating with RISE for EDOR test
200507 – Emotra – PM – Effects of Covid-19 on Emotra’s operations
200406 – Emotra- PM -Trade in subscription warrants on spotlight stock market
200403 – Emotra- PM – Final day for tradel in BTU
200326 – Emotra- PM – Liquidity guarantor
200325 – Emotra – PM – Emotra signs collaboration agreement for clinical studies
200323 – Emotra- PM – Results of the rights issue
200309 – Emotra – PM – Emotra close to sealing collaboration agreement for clinical studies
200224 – Emotra- PM – Issue resolution FINAL_Correction_clean
200226 – Emotra – PM – Correction regarding our Q1 2020 report
200224 – Emotra- PM – Issue resolution
200212 – Emotra – PM – Emotra comments on share trade volumes and the share price rise
200206 – Emotra – PM – Emotra signs agreement for research collaboration
191127 – Emotra -PM – Lectures
190515 – Emotra- PM – Communiqué from AGM
190509- Emotra – PM – EDOR identifies patients with a higher risk of depression relapse
190503- Emotra – PM – patent approved in USA
190424 – Emotra- PM – Documents for AGM
190415 – Emotra- PM – Notice AGM
190305 – Emotra – PM – Comments on communication from individual researcher
181120- Emotra – PM – Important discoveries in research
181116- Emotra – PM – Letter of intent with psychiatric hospital
181101 – Emotra- PM – Issue resolution
181024 – Emotra- PM – Emotra changes CEO and Chairman
181018 – Emotra- PM – Introduction at German hospital
180904- Emotra – PM – New publication demonstrates the strength of EDOR tests
180730- Emotra – PM – Patent approved in Japan
180509 – Emotra- PM – Communiqué AGM
180507 – Emotra – PM- Agreement with Univeristy in Warsaw
180418 – Emotra- PM – Documents for AGM
180409 – Emotra- PM – Notice AGM
180309 – Emotra- PM – First contract signed
171130 – Emotra – PM- Changed training seminar planning
170718 – Emotra – Final day for trading in PSS
170703 – Emotra – Communiqué from AGM
170626 – Emotra – Flagging notification
170626 – Emotra – Results of the rights issue
70609 – Emotra – PM – Documents for AGM
170607- Emotra- Subscription period begun
170531 – Emotra – Publication of memorandum
170526 – Emotra – Issue resolution
170519 – Emotra- PM – EGM bulletin
170515 – PM – Emotra announces launch shortly_EN
170503 – Emotra – Notice of EGM_EN
170503 – Emotra – Board proposes authorisation
170331 – Emotra – PM – Consensus meeting supports EDOR launch plans
170313 – Emotra – PM – Horizon 2020- application rejected
161128-emotra-pm-horizon-2020-application-rejected-en
160727 – Emotra – PM – Analysis of the baseline material in EUDOR-A
160427 – Emotra – PM – AGM bulletin
160405- Emotra- PM- Documents for AGM
160323- Emotra- PM- Notice of AGM
160311 – Emotra – PM – First stage of study completed
160121 – Emotra – PM – EU grants Emotra financial support
151026 – Emotra – PM – Last day for trading in PSS
151012 – Emotra – PM – Flagging notice
151012- Emotra – PM – Results of new share issue
150923 – Emotra – PM – The subscription period starts
150922- Emotra – PM – PRV Approves Emotra’s Patent Application
150921- Emotra – PM – Meeting in Rome
150910 – Emotra – PM – Resolution on share issue
150901 – Emotra – PM – Communiqué from extraordinary general meeting
150710- Emotra – PM – EDOR presentation in the US
150512- Emotra – PM – EU H2020 application denied
150428 – Emotra – PM – AGM bulletin
150402- Emotra- PM- Annual report 2014
150401- Emotra – PM – EDOR at Vienna convention
150327- Emotra – PM – International conventions
150327- Emotra- PM- Notice of Emotra’s AGM
150318- Emotra – PM – EU H2020 application
150213- Emotra – PM – EGM approved share split
150115- Emotra – PM – Notice of EGM
141217- Emotra – PM – EU card granted by Västra Götalandsregionen-en
141024- Emotra – PM – Honourable appointment for Lars-Håkan Thorell
140930- Emotra – PM – Agreement with researchers
140919- Emotra – PR – Ethics committee approval
140813- Emotra – PR – International symposium 2015
140609- Emotra – PM – Development project completed
140415- Emotra – PM – Kick-off meeting in Rome
140401- Emotra – PM -Agreement with clinic in Rostock
140328- Emotra – PM – Notice AGM
140324- Emotra – PM -Agreement with clinic in Lisbon
140324- Emotra – PM – Kick-off meeting in Rome
140320- Emotra – PM -Agreement with clinic in Tübingen
140317- Emotra – PM – Agreement with two more clinics
140307- Emotra – PM – Agreement with three clinics
140217- Emotra – PM – Agreement with Swedish hospitals
140212- Emotra – PM – Agreement with National Institute of Psychiatry, Budapest
140206- Emotra – PM – Agreement with University of Cluj-Napoca
140203 – Emotra – PR – Subscription
140123- Emotra – PM – Agreements with universities of Bari and Piemonte
140123 – Emotra – PR – Agreement with University of Rome
140117 – Emotra – PR – Agreement with University of Genoa
140116 – Emotra – PM – New share issue begins
140110 – Emotra – PM – Agreement with EPA-SS
140108- Emotra – PM – EGM Bulletin
131227- Emotra- PM- Agreement with opinion leader
131219_2 – Emotra – PM – Rights issue decission
131219 – Emotra – PM – Notice of extraordinary general meeting
Press release September 18 2013
Press release September 13 2013
Press release September 11 2013
Pressmeddelande från Emotra 20130423
Pressmeddelande från Emotra 20130328
Pressmeddelande från Emotra 20130315
Pressmeddelande från Emotra 20130225
Pressmeddelande fran Emotra 20130220